Uni Eropa - Swedia - EMA (European Medicines Agency)

nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibakteriella medel för systemiskt bruk, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. hänsyn bör tas till officiella riktlinjer för lämplig användning av antibakteriella medel.

Uni Eropa - Swedia - EMA (European Medicines Agency)

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - lipidmodifierande medel - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.

Uni Eropa - Swedia - EMA (European Medicines Agency)

advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.

Uni Eropa - Swedia - EMA (European Medicines Agency)

ecuphar nv - enflicoxib - antiinflammatoriska och antirheumatiska produkter - hundar - for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

Uni Eropa - Swedia - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 och 5.

Uni Eropa - Swedia - EMA (European Medicines Agency)

proveca pharma limited - enalapril (maleate) - hjärtsvikt - agenter som verkar på renin-angiotensinsystemet - treatment of heart failure.

Swedia - Swedia - Läkemedelsverket (Medical Products Agency)

h. lundbeck a/s - escitalopram - munsönderfallande tablett - 10 mg - mannitol hjälpämne; escitalopram 10 mg aktiv substans - escitalopram

Swedia - Swedia - Läkemedelsverket (Medical Products Agency)

h. lundbeck a/s - escitalopram - munsönderfallande tablett - 20 mg - mannitol hjälpämne; escitalopram 20 mg aktiv substans - escitalopram

Swedia - Swedia - Läkemedelsverket (Medical Products Agency)

hec pharm gmbh - klaritromycin - filmdragerad tablett - 250 mg - klaritromycin 250 mg aktiv substans - klaritromycin

Swedia - Swedia - Läkemedelsverket (Medical Products Agency)

hec pharm gmbh - klaritromycin - filmdragerad tablett - 500 mg - klaritromycin 500 mg aktiv substans - klaritromycin